Richard Holder, president and CEO commented, "The acquisition of Bridgemedica is another key step in the growth of our Life Sciences segment through significantly expanding our new product design and development capabilities. This acquisition aligns perfectly with our strategic plan and long-term objective to further diversify our portfolio and expand into markets that we believe have strong growth potential. Bridgemedica significantly expands our new product design engineering and development capabilities through its expertise in rapidly moving from the concept design stage through development and full-scale product manufacturing as we continue to focus on providing more value add and innovative solutions for our customers."
NN, Inc., a diversified industrial company combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for a variety of markets on a global basis. Headquartered in Johnson City, Tenn., NN has 36 facilities in North America, Western Europe, Eastern Europe, South America, and China.